Epileptic seizures are a common feature associated with inherited mitochondrial diseases. This study investigated the role of mitochondrial oxidative stress in epilepsy resulting from mitochondrial dysfunction using cross-bred mutant mice lacking mitochondrial manganese superoxide dismutase (MnSOD or SOD2) and a lipophilic metalloporphyrin catalytic antioxidant. Video-EEG monitoring revealed that in the second to third week of postnatal life (P14-P21) B6D2F2 Sod2 −/− mice exhibited frequent spontaneous motor seizures providing evidence that oxidative stress-induced mitochondrial dysfunction may contribute to epileptic seizures. To confirm the role of mitochondrial oxidative stress in epilepsy a newly developed lipophilic metalloporphyrin, AEOL 11207, with high potency for catalytic removal of endogenously generated reactive oxygen species was utilized. AEOL 11207-treated Sod2 −/− mice showed a significant decrease in both the frequency and duration of spontaneous seizures but no effect on seizure severity. A significant increase in the average lifespan of AEOL 11207-treated Sod2 −/− mice compared to vehicle-treated Sod2 −/− mice was also observed.
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Indices of mitochondrial oxidative stress and damage (aconitase inactivation, 3-nitrotyrosine formation, and depletion of reduced coenzyme A) and ATP levels affecting neuronal excitability were significantly attenuated in the brains of AEOL 11207-treated Sod2 −/− mice compared to vehicle-treated Sod2 −/− mice. The occurrence of epileptic seizures in Sod2 −/− mice and the ability of catalytic antioxidant therapy to attenuate seizure activity, mitochondrial dysfunction, and ATP levels suggest that ongoing mitochondrial oxidative stress can contribute to epilepsy associated with mitochondrial dysfunction and disease. © 2011 Elsevier Inc. All rights reserved.
Introduction
Epileptic seizures commonly occur in patients with inherited mitochondrial disease (Mecocci et al., 1993; Wallace et al., 1988) suggesting that mitochondrial dysfunction can contribute to seizures (Kunz, 2002; Patel, 2004) . General and partial seizures with mitochondrial encephalopathy can be caused by mitochondrial dysfunction arising from mitochondrial mtDNA mutations (Shoffner et al., 1990; Wallace et al., 1988) . Mitochondrial dysfunction is a consequence of many neurological insults such as neonatal or adult hypoxia, trauma and infections which are known risk factors for epilepsy development (Beal, 1998; Douglas et al., 2010; Jensen et al., 1991 Jensen et al., , 1992 Mustafa et al., 2010) . These data strongly suggest that mitochondrial dysfunction per se may be a common pathway contributing to epilepsy development. Mitochondria have important functions that include cellular ATP production, control of apoptotic/necrotic cell death, reactive oxygen species (ROS) formation and calcium homeostasis. Which of these critical mitochondrial functions contributes to increased seizure susceptibility associated with inherited or acquired epilepsies remains unknown. Results from this and other laboratories suggest that mitochondrial oxidative stress and resultant dysfunction are not only a consequence of seizure activity but also render the brain more susceptible to age-related epileptic seizures (Jarrett et al., 2008; Kudin et al., 2002; Liang et al., 2000; Liang and Patel, 2004; Waldbaum et al., 2010) .
To understand the role of oxidative stress in epilepsy associated with mitochondrial disease it is useful to utilize an animal model in which spontaneous epileptic seizures arise due to increased steadystate mitochondrial ROS. Mutant mice lacking manganese superoxide dismutase (MnSOD or SOD2), a critical mitochondrial antioxidant, provide such a model. Mitochondrial disease has been characterized in SOD2 deficient mice generated in several background strains with phenotypes characteristic of increased steady-state mitochondrial ROS. Sod2 −/− mice bred from a C57B6 background (B6 Sod2 −/− ) are neonatal lethal (Lebovitz et al., 1996) , whereas CD-1 Sod2 
